NASDAQ:PRPO - Precipio Stock Price, News & Analysis

$2.49
-0.03 (-1.19 %)
(As of 09/16/2019 10:03 AM ET)
Today's Range
$2.47
Now: $2.4937
$2.4937
50-Day Range
$2.42
MA: $2.71
$2.98
52-Week Range
$1.65
Now: $2.4937
$10.80
Volume11,997 shs
Average Volume102,299 shs
Market Capitalization$15.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.82
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRPO
CUSIPN/A
Phone203-787-7888

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.86 million
Book Value$2.66 per share

Profitability

Net Income$-15,690,000.00
Net Margins-614.15%

Miscellaneous

Employees42
Market Cap$15.19 million
Next Earnings Date11/18/2019 (Estimated)
OptionableNot Optionable

Receive PRPO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter.


Precipio (NASDAQ:PRPO) Frequently Asked Questions

What is Precipio's stock symbol?

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

When did Precipio's stock split? How did Precipio's stock split work?

Precipio shares reverse split on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split.

How were Precipio's earnings last quarter?

Precipio (NASDAQ:PRPO) released its earnings results on Friday, August, 9th. The biotechnology company reported ($1.05) earnings per share for the quarter. The biotechnology company had revenue of $0.94 million for the quarter. Precipio had a negative net margin of 614.15% and a negative return on equity of 119.23%. View Precipio's Earnings History.

When is Precipio's next earnings date?

Precipio is scheduled to release their next quarterly earnings announcement on Monday, November 18th 2019. View Earnings Estimates for Precipio.

Has Precipio been receiving favorable news coverage?

Press coverage about PRPO stock has been trending somewhat positive on Monday, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Precipio earned a daily sentiment score of 0.9 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Precipio.

Are investors shorting Precipio?

Precipio saw a decline in short interest in August. As of August 31st, there was short interest totalling 290,600 shares, a decline of 8.7% from the July 31st total of 318,200 shares. Based on an average daily volume of 317,700 shares, the days-to-cover ratio is presently 0.9 days. Approximately 4.9% of the shares of the company are short sold. View Precipio's Current Options Chain.

Who are some of Precipio's key competitors?

What other stocks do shareholders of Precipio own?

Who are Precipio's key executives?

Precipio's management team includes the folowing people:
  • Mr. Ilan Danieli, Founder, Pres, CEO & Director (Age 47)
  • Mr. Carl R. Iberger, CFO & Sec. (Age 66)
  • Mr. Ahmed Zaki Sabet, Chief Operating Officer (Age 33)
  • Mr. Douglas Sites, VP of Sales
  • Mr. Ayman Mohamed, Sr. VP of R&D and Laboratory Operations (Age 34)

Who are Precipio's major shareholders?

Precipio's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (1.32%), SeaCrest Wealth Management LLC (0.92%), Morgan Stanley (0.42%) and BlackRock Inc. (0.23%). Company insiders that own Precipio stock include Ilan Danieli and Randal J Kirk. View Institutional Ownership Trends for Precipio.

Which major investors are selling Precipio stock?

PRPO stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. View Insider Buying and Selling for Precipio.

Which major investors are buying Precipio stock?

PRPO stock was acquired by a variety of institutional investors in the last quarter, including SeaCrest Wealth Management LLC, Morgan Stanley and BlackRock Inc.. View Insider Buying and Selling for Precipio.

How do I buy shares of Precipio?

Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Precipio's stock price today?

One share of PRPO stock can currently be purchased for approximately $2.4937.

How big of a company is Precipio?

Precipio has a market capitalization of $15.19 million and generates $2.86 million in revenue each year. Precipio employs 42 workers across the globe.View Additional Information About Precipio.

What is Precipio's official website?

The official website for Precipio is http://www.precipiodx.com/.

How can I contact Precipio?

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The biotechnology company can be reached via phone at 203-787-7888 or via email at [email protected]


MarketBeat Community Rating for Precipio (NASDAQ PRPO)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  239 (Vote Outperform)
Underperform Votes:  160 (Vote Underperform)
Total Votes:  399
MarketBeat's community ratings are surveys of what our community members think about Precipio and other stocks. Vote "Outperform" if you believe PRPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Call Option Volume

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel